Protai
Tel Aviv
About Protai
Protai empowers drug discovery with proteomics and artificial intelligence to unlock new layers of biological insights and to combat complex diseases. Protai's platform has made a leap in solving how drug candidates are created and validated, facilitating quicker and more advanced drug discovery.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $20.0M
- Funding stage: Seed
- Last round: Seed (Mar 2023)
- Website: protai.bio
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/protai-73592 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.